Pharmacokinetic Drug-Drug Interactions Between First Line Anti-TB (Rifampicin, Isoniazid and Pyrazinamide) and Anti-Diabetic Drugs (Metformin and Sulphonylureas) (Record no. 11261)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00658nam a22001577a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220811124412.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220811b ||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | NIRT Library |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mary Rebecca, Y |
| 110 ## - MAIN ENTRY--CORPORATE NAME | |
| Relator code | Department of Biochemistry |
| Corporate name or jurisdiction name as entry element | ICMR-National Institute for Research in Tuberculosis |
| 245 ## - TITLE STATEMENT | |
| Title | Pharmacokinetic Drug-Drug Interactions Between First Line Anti-TB (Rifampicin, Isoniazid and Pyrazinamide) and Anti-Diabetic Drugs (Metformin and Sulphonylureas) |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Department of Biochemistry, ICMR-NIRT, Chennai |
| Date of publication, distribution, etc. | April 2021 |
| Name of publisher, distributor, etc. | Dr. M.G.R. Medical University, Chennai |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1-174 p. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Thesis |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Use restrictions | Not for loan | Home library | Current library | Date acquired | Serial Enumeration / chronology | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Restricted Access | Not For Loan | National Institute for Research in Tuberculosis | National Institute for Research in Tuberculosis | 11/08/2022 | April 2021 | T0097 | 11/08/2022 | 11/08/2022 | Thesis |